rs200525458

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_001387283.1(SMARCA4):​c.4259C>A​(p.Ala1420Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000694 in 1,441,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1420G) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

SMARCA4
NM_001387283.1 missense

Scores

1
1
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.603

Publications

0 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001387283.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
NM_001387283.1
MANE Plus Clinical
c.4259C>Ap.Ala1420Glu
missense
Exon 30 of 36NP_001374212.1
SMARCA4
NM_003072.5
MANE Select
c.4171-1761C>A
intron
N/ANP_003063.2
SMARCA4
NM_001128849.3
c.4259C>Ap.Ala1420Glu
missense
Exon 30 of 36NP_001122321.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
ENST00000646693.2
MANE Plus Clinical
c.4259C>Ap.Ala1420Glu
missense
Exon 30 of 36ENSP00000495368.1
SMARCA4
ENST00000643549.1
c.4160C>Ap.Ala1387Glu
missense
Exon 29 of 35ENSP00000493975.1
SMARCA4
ENST00000344626.10
TSL:1 MANE Select
c.4171-1761C>A
intron
N/AENSP00000343896.4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.94e-7
AC:
1
AN:
1441468
Hom.:
0
Cov.:
28
AF XY:
0.00
AC XY:
0
AN XY:
716672
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32344
American (AMR)
AF:
0.00
AC:
0
AN:
41218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25808
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38552
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82434
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53082
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5646
European-Non Finnish (NFE)
AF:
9.07e-7
AC:
1
AN:
1102768
Other (OTH)
AF:
0.00
AC:
0
AN:
59616
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Uncertain
24
DANN
Benign
0.89
DEOGEN2
Benign
0.0057
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.0060
N
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.29
D
MetaRNN
Benign
0.16
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.60
PrimateAI
Uncertain
0.53
T
Sift4G
Benign
1.0
T
Polyphen
0.96
D
Vest4
0.23
MutPred
0.36
Loss of MoRF binding (P = 0.0353)
MVP
0.15
ClinPred
0.29
T
GERP RS
-0.51
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.75
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.75
Position offset: -4

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200525458; hg19: chr19-11150222; API